Article Information
History
- February 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Narayanaiah Cheedarla1,9,
- Hans P. Verkerke1,2,9,
- Sindhu Potlapalli1,
- Kaleb Benjamin McLendon1,
- Anamika Patel3,
- Filipp Frank3,
- Gregory L. Damhorst4,
- Huixia Wu1,
- William Henry O’Sick1,
- Daniel Graciaa4,
- Fuad Hudaib1,
- David N Alter1,
- Jeannette Bryksin1,
- Eric A. Ortlund3,
- Jeanette Guarner1,
- Sara Auld4,
- Sarita Shah4,5,
- Wilbur Lam6,
- Dawn Mattoon7,
- Joseph M Johnson7,
- David H Wilson7,
- Madhav V. Dhodapkar8,
- Sean R. Stowell2,*,
- Andrew S. Neish1,* and
- John D. Roback1,*
- 1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
- 2Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA
- 3Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA
- 4Department of Medicine, Division of infectious diseases, Emory University, Atlanta, GA 30322, USA
- 5Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
- 6Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
- 7Quanterix Corporation, 900 Middlesex Turnpike, Billerica, MA 01821
- 8Department of Hematology/Medical Oncology, Emory University, Atlanta, GA
- ↵*Shared senior authorship, correspondence to srstowell{at}bwh.harvard.edu, aneish{at}emory.edu and jroback{at}emory.edu
↵9 These authors contributed equally as a first authors
Posted February 02, 2022.
Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against native-like vaccine and delta variant spike trimers
